Company / Operating Cash Flow per Share
Cytokinetics Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4246.43
FY2025
5-year range
-$4246.43 / -$1.68
FY2021-FY2025
Trend
-108919.8%
vs FY2024
Sector context
#212 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -108920% YoY in FY2025, a notable deviation from the 9-year average annual change of -12295%.
Based on SEC 10-K filings.
-4246.43 in FY2025.
Declined from $-4.37 to $-4246.43 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 212This company -$4246.43 Sector average -$14.72
▼
-28741.2% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 108919.8% year-over-year.
- Ranks #212 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4246.43 | -108919.8% |
| FY2024 | -$3.90 | +10.8% |
| FY2023 | -$4.37 | -23.7% |
| FY2022 | -$3.53 | -110.2% |
| FY2021 | -$1.68 | -1434.6% |
| FY2020 | $0.13 | +108.2% |
| FY2019 | -$1.54 | +16.9% |
| FY2018 | -$1.85 | +1.9% |
| FY2017 | -$1.89 | -307.3% |
| FY2016 | $0.91 | +637.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026